MED

Listed Company · HNX

Price
20,400
Latest close
31 Mar 2026
P/E 14.5x
EPS (TTM) 1,407
ROE (TTM) 5.3%
P/B 0.8x
BVPS (Latest) 26,652
ROA (TTM) 3.6%

What Is Changing

MED has not yet shown a broad-based top-line recovery. Revenue posted -17.2% YoY, but net margin reached 4.32% with an additional +0.9pp improvement versus the prior year. The next question is whether current profit momentum can hold through the next cycle.

  • Net Margin expanded consistently from 2.92% in 2023 to 4.32% in 2025.
  • Revenue decreased 17.2% YoY to VND 366.8bn in 2025.
  • Net Income reached a multi-period high at VND 15.8bn in 2025.
Metric 2025 2024 2023 2022 2021
Revenue 366.8 443.1 402.7 401.1 344.0
Growth -17% +10% +0% +17%
Net Income 15.8 15.2 11.7 6.0 3.7
Net Margin 4.32% 3.44% 2.92% 1.50% 1.06%

Financial Statements

Profitability

Net margin reached 4.32% while Revenue posted -17.2% YoY.

Balance Sheet

Inventory stood at 93.2bn, liabilities at 126.0bn, and equity at 331.3bn.

Cash Flow

Operating cash flow was -5.4bn in 2025, while investing cash flow was -4.0bn.

Financing cash flow: -8.9bn.

Item 2025 2024 2023 2022 2021
Net Revenue
366.8 443.1 402.7 401.1 344.0
Cost of Goods Sold
281.0 350.6 319.7 322.6 0.0
Gross Profit
85.8 92.6 83.1 78.4 68.1
Financial Expenses
3.7 5.9 6.7 7.5 -5.5
Selling Expenses
4.7 8.0 12.7 14.4 -16.0
General and Administrative Expenses
58.6 62.4 56.2 54.9 -43.2
Operating Profit
20.1 18.5 15.3 7.4 8.2
Profit Before Tax
20.7 19.4 14.9 8.2 5.5
Net Income
15.8 15.2 11.7 6.0 3.7
Profit Attributable to Parent
15.8 15.2 11.7 6.0 3.7
Earnings per Share
1,276.00 1,229.00 946.00 554.00 581.00

Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.